<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="SARS-CoV-2 Coronavirus RNA virus Respiratory disease SARS-CoV-2 inhibitors 1 Introduction" exact="Coronavirus disease 2019" post="(COVID-19) is a pandemic faced by the global community"/>
 <result pre="also exhibited potent activity against SARS-CoV-2 pseudovirus infection and live" exact="SARS-CoV-2 infection" post="in vitro with IC50 values of 15.8Â nM and"/>
 <result pre="was developed by Gilead Sciences for the treatment of the" exact="Ebola" post="virus [85]. Remdesivir is in the frontline in ongoing"/>
 <result pre="that has shown promise as a therapeutic intervention for the" exact="Ebola" post="virus [104], [105], [106], [107]. Favipiravir was shown to"/>
 <result pre="derivatives were capable of blocking the viral entry of the" exact="Ebola" post="virus, SARS-CoV, and MERS-CoV into the cell by blocking"/>
 <result pre="trial highlighted the importance of azithromycin for the management of" exact="SARS-CoV-2 infection" post="[117]. A total of 36 patients were enrolled for"/>
 <result pre="dwelled on to consider azithromycin as viable adjuvant therapy for" exact="SARS-CoV-2 infection." post="Fascinatingly, azithromycin has been reported to be active against"/>
 <result pre="been reported to be active against other RNA viruses like" exact="Ebola" post="and Zika virus in vitro[118], [119]. Further studies might"/>
 <result pre="the efficacy of dexamethasone in patients with ARDS secondary to" exact="SARS-CoV-2 infection" post="(NCT04325061). Zhou et al. demonstrated that inflammatory and pro-inflammatory"/>
 <result pre="under clinical investigation (NCT04321993) as a potential drug for treating" exact="SARS-CoV-2 infection." post="3.6 Traditional Chinese Medicine (TCM) and natural products Traditional"/>
 <result pre="Republic of China has recommended the use of TCM for" exact="Covid-19" post="since the fourth version of Diagnosis and Treatment Protocol"/>
 <result pre="of interferon-Î±2b and ribavirinSci. Rep.3201310.1038/srep01686 15ChanJ.F.W.ChanK.H.KaoR.Y.T.ToK.K.W.ZhengB.J.LiC.P.Y.LiP.T.W.DaiJ.MokF.K.Y.ChenH.HaydenF.G.YuenK.Y.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect.67201360661610.1016/j.jinf.2013.09.02924096239 16ElshabrawyH.A.FanJ.HaddadC.S.RatiaK.BroderC.C.CaffreyM.PrabhakarB.S.Identification of a broad-spectrum antiviral small molecule"/>
 <result pre="fusogenic mechanism and identification of fusion inhibitorsLancet363200493894710.1016/S0140-6736(04)15788-715043961 26LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.WangQ.ChanJ.F.W.DuL.YuF.MaC.YeS.YuenK.Y.ZhangR.JiangS.Structure-based discovery of" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitorNat. Commun.5201410.1038/ncomms4067 27XiaS.YanL.XuW.AgrawalA.S.AlgaissiA.TsengC.T.K.WangQ.DuL.TanW.WilsonI.A.JiangS.YangB.LuL.A pan-coronavirus fusion inhibitor targeting"/>
 <result pre="endoproteasesBiochim. Biophys. Acta - Rev. Biomembr.1469200012113210.1016/S0304-4157(00)00014-9 51MilleJ.K.WhittakerG.R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike proteinProc."/>
 <result pre="58GordonC.J.TchesnokovE.P.FengJ.Y.PorterD.P.GotteM.The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirusjbc.AC120.013056J. Biol. Chem.202010.1074/jbc.ac120.013056 59SubissiL.PosthumaC.C.ColletA.Zevenhoven-DobbeJ.C.GorbalenyaA.E.DecrolyE.SnijderE.J.CanardB.ImbertI.One severe acute respiratory syndrome coronavirus"/>
 <result pre="2020). 85WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.LarsonN.StrickleyR.WellsJ.StuthmanK.S.Van TongerenS.A.GarzaN.L.DonnellyG.ShurtleffA.C.RettererC.J.GharaibehD.ZamaniR.KennyT.EatonB.P.GrimesE.WelchL.S.GombaL.WilhelmsenC.L.NicholsD.K.NussJ.E.NagleE.R.KugelmanJ.R.PalaciosG.DoerfflerE.NevilleS.CarraE.ClarkeM.O.ZhangL.LewW.RossB.WangQ.ChunK.WolfeL.BabusisD.ParkY.StrayK.M.TranchevaI.FengJ.Y.BarauskasO.XuY.WongP.BraunM.R.FlintM.McMullanL.K.ChenS.S.FearnsR.SwaminathanS.MayersD.L.SpiropoulouC.F.LeeW.A.NicholS.T.CihlarT.BavariS.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature531201638138510.1038/nature1718026934220 86GordonC.J.TchesnokovE.P.WoolnerE.PerryJ.K.FengJ.Y.PorterD.P.GotteM.Remdesivir is a direct-acting antiviral"/>
 <result pre="The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from" exact="Middle East respiratory syndrome" post="coronavirus., J. Biol. Chem. (2020). doi:10.1074/jbc.AC120.013056. 96CvetkovicR.S.GoaK.L.Lopinavir/ritonavir: A review"/>
 <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.5820144875488410.1128/AAC.03011-1424841269 99ChanJ.F.-W.YaoY.YeungM.-L.DengW.BaoL.JiaL.LiF.XiaoC.GaoH.YuP.CaiJ.-P.ChuH.ZhouJ.ChenH.QinC.YuenK.-Y.Treatment with"/>
 <result pre="the antiviral agent T-705 (favipiravir)Mol. Pharmacol.84201361562910.1124/mol.113.08724723907213 104OestereichL.LÃ¼dtkeA.WurrS.RiegerT.MuÃ±oz-FontelaC.GÃ¼ntherS.Successful treatment of advanced" exact="Ebola" post="virus infection with T-705 (favipiravir) in a small animal"/>
 <result pre="Mentre, X. Anglaret, D. Malvy, Experimental Treatment with Favipiravir for" exact="Ebola" post="Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm"/>
 <result pre="MERS-CoV-infected rhesus macaquesNat. Med.1920131313131710.1038/nm.336224013700 112OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alfa-2a for severe" exact="Middle East respiratory syndrome" post="coronavirus infection: A retrospective cohort studyLancet Infect. Dis.1420141090109510.1016/S1473-3099(14)70920-X25278221 113ArabiY.M.ShalhoubS.MandourahY.Al-HameedF.Al-OmariA.Al"/>
 <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov.620201610.1038/s41421-020-0156-032194981 127YaoX.YeF.ZhangM.CuiC.HuangB.NiuP.LiuX.ZhaoL.DongE.SongC.ZhanS.LuR.LiH.TanW.LiuD.In vitro antiviral activity and projection"/>
 <result pre="Res.11020149410310.1016/j.antiviral.2014.07.01425108173 136RossignolJ.F.Nitazoxanide, a new drug candidate for the treatment of" exact="Middle East respiratory syndrome" post="coronavirusJ. Infect. Public Health9201622723010.1016/j.jiph.2016.04.00127095301 137A.G. Canga, A.M.S. Prieto, M.J."/>
</results>
